These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 29976470)

  • 21. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Temmink SJD; Peeters KCMJ; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Melenhorst J; Burger JWA; Wolthuis A; Renehan AG; Figueiredo NL; Pares O; Martling A; Perez RO; Beets GL; van de Velde CJH; Nilsson PJ;
    Br J Surg; 2023 May; 110(6):676-684. PubMed ID: 36972213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.
    Bahadoer RR; Peeters KCMJ; Beets GL; Figueiredo NL; Bastiaannet E; Vahrmeijer A; Temmink SJD; Meershoek-Klein Kranenbarg WME; Roodvoets AGH; Habr-Gama A; Perez RO; van de Velde CJH; Hilling DE;
    Br J Surg; 2021 Dec; 109(1):114-120. PubMed ID: 34738104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
    Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
    Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is watch and wait a safe and effective way to treat rectal cancer in older patients?
    Haak HE; Maas M; Lambregts DMJ; Beets-Tan RGH; Beets GL;
    Eur J Surg Oncol; 2020 Mar; 46(3):358-362. PubMed ID: 31982206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
    Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
    Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer.
    van der Sande ME; Figueiredo N; Beets GL
    Ann Surg; 2021 Dec; 274(6):e1056-e1062. PubMed ID: 32039985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
    Kong JC; Guerra GR; Warrier SK; Ramsay RG; Heriot AG
    Dis Colon Rectum; 2017 Mar; 60(3):335-345. PubMed ID: 28177997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial].
    Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305
    [No Abstract]   [Full Text] [Related]  

  • 30. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy.
    Yu G; Lu W; Jiao Z; Qiao J; Ma S; Liu X
    World J Surg Oncol; 2021 Oct; 19(1):305. PubMed ID: 34663341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?
    Kaul S; Rao C; Mane R; Tan KL; Khan AHA; Hussain MS; Shafi MA; Buettner F; Banerjee S; Boulton R; Bhargava A; Huang J; Hanson M; Raouf S; Ball S; Rajendran N
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e25-e34. PubMed ID: 34454807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 33. Low rectal cancer treatment strategies: a cohort study assessing watch and wait.
    Pinto JC; Pereira AD; Pimenta A; Pedro C; Fernandez G; Marques I; Miguel I; Freire J; Maciel J; Venâncio J; D'Orey L; Mirones L; Limbert M; Labareda M; Chaves P; Fonseca R; Barroca R; Ferreira T; Marques T; Rosa I
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2631-2638. PubMed ID: 32435893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
    Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
    JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
    Balasuriya HD; Timon C; Entriken F; Neely D; Herron J; Tang C; Van Hazel G; Warner MW
    ANZ J Surg; 2022 Nov; 92(11):2961-2967. PubMed ID: 35841184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
    Custers PA; Hupkens BJP; Grotenhuis BA; Kuhlmann KFD; Breukink SO; Beets GL; Melenhorst J;
    Colorectal Dis; 2022 Apr; 24(4):401-410. PubMed ID: 35060263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis.
    Li J; Ma Y; Wen L; Zhang G; Yao X
    Expert Rev Anticancer Ther; 2023 May; 23(5):555-564. PubMed ID: 36795784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth.
    Al-Najami I; Jones HJ; Dickson EA; Muirhead R; Deding U; James DR; Cunningham C
    Surg Oncol; 2021 Jun; 37():101574. PubMed ID: 33853031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
    Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
    Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.